Amylin and amylin agonists for treating psychiatric diseases and disorders

Details for Australian Patent Application No. 2006230602 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Mack, Christine M.; Laugero, Kevin D.; Hanley, Michael; Parkes, David G.; Young, Andrew A.

Agent Freehills

Pub. Number AU-B-2006230602

PCT Pub. Number WO2006/105527

Priority 60/667,335 31.03.05 US; 60/760,583 20.01.06 US; 60/675,441 28.04.05 US; 60/666,681 31.03.05 US

Filing date 31 March 2006

Wipo publication date 5 October 2006

Acceptance publication date 15 July 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/105527 Priority application(s): WO2006/105527

15 July 2010 Application Accepted

  Published as AU-B-2006230602

11 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006230612-Human Niemann Pick C1-Like 1 gene (NPC1L1) polymorphisms and methods of use thereof

2006230595-Novel tampon applicator